BIOCAD is one of the largest innovative biotechnology companies in Russia. For over 20 years, the company has successfully integrated world-class R&D centers, modern pharmaceutical and biotechnological manufacturing, and a system of preclinical
and clinical trials that comply with international standards.
BIOCAD conducts the full cycle of drug creation:
from molecule discovery and genetic engineering to mass production and marketing support. The company's drugs are intended for the therapy of oncological, autoimmune, and other socially significant diseases.
Product Portfoliocurrently consists of 68 medicinal products, 13 of which are original and 23 are biological products. More than 40 products are at various stages of development.
Facilities- more than 40 laboratories and 7 production complexes
Employees- more than 3,000 people, one third of whom are scientists and researchers
Mission
Improving and extending people's lives by providing effective, safe, and affordable comprehensive solutions in the field of drug supply.